Economic evaluations are important tools that help inform healthcare decision-making by weighing the costs and benefits of different interventions. They involve the comparison of the costs and effects of different healthcare interventions to determine which option provides the greatest value for money. Critical appraisal of economic evaluations is important to ensure that the results are reliable, valid and relevant to clinical practice.
When critically appraising economic evaluations, the following elements should be considered:
One useful tool for assessing the quality of economic evaluations is the Drummond checklist, which includes 35 questions covering the above elements as well as other considerations such as time horizon, discounting and transferability of results.
Summary of critical appraisal of economic evaluations:
Study Design | Key Considerations | Strengths | Limitations |
Cost-effectiveness analysis (CEA) | Use of a well-defined measure of effectiveness Comparing costs and consequences of two or more interventions Identification, measurement and valuation of costs and benefits | Provides a measure of cost-effectiveness Useful in decision-making regarding the allocation of resources | Relies on the validity of the measure of effectiveness Difficulty in measuring and valuing non-health benefits and costs May not capture long-term effects |
Cost-utility analysis (CUA) | Use of quality-adjusted life years (QALYs) as a measure of effectiveness Comparing costs and consequences of two or more interventions Identification, measurement and valuation of costs and benefits | Provides a measure of cost-effectiveness that accounts for both quality and quantity of life Useful in decision-making regarding allocation of resources | Relies on the validity of the measure of QALYs Difficulty in measuring and valuing non-health benefits and costs May not capture long-term effects |
Cost-benefit analysis (CBA) | Comparing costs and benefits of two or more interventions Identification, measurement and valuation of costs and benefits in monetary terms | Provides a measure of cost-effectiveness that accounts for both monetary costs and benefits Useful in decision-making regarding the allocation of resources | Requires the identification and valuation of all costs and benefits, including those that are difficult to quantify May not capture long-term effects |
Cost-consequence analysis (CCA) | Separation of costs and consequences into distinct categories without combining them into a single measure | Provides detailed information about costs and consequences that can be useful for decision-making | Does not provide a single measure of cost-effectiveness May not capture long-term effects Difficult to compare results across studies |
It is important to note that economic evaluations are just one piece of information that should be considered in healthcare decision-making, alongside other factors such as clinical effectiveness, safety, patient preferences and equity considerations.
References: